Rong Yang
Directeur/Membre du Conseil chez NATURE'S SUNSHINE PRODUCTS, INC.
Fortune : 432 076 $ au 30/04/2024
Profil
Rong Yang is currently the Chief Executive Officer at Fosun Pharma USA, Inc. and an Independent Director at Nature's Sunshine Products, Inc. Yang holds a Master's in Business Administration from Harvard University, an undergraduate degree from Beijing Foreign Studies University, and a graduate degree from Nankai University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/05/2024 | 22 249 ( 0,12% ) | 432 076 $ | 30/04/2024 |
Postes actifs de Rong Yang
| Sociétés | Poste | Début |
|---|---|---|
| NATURE'S SUNSHINE PRODUCTS, INC. | Directeur/Membre du Conseil | 01/06/2022 |
Fosun Pharma USA, Inc.
 Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Directeur Général | 01/01/2022 |
Formation de Rong Yang
| Beijing Foreign Studies University | Undergraduate Degree |
| Nankai University | Graduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NATURE'S SUNSHINE PRODUCTS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Health Technology |
